Today

Agents

Chat

Arena

Discover

More

App

Amgen Inc <AMGN.O>: Argus Research Raises Target Price to $460

AMGN•2026-08-19

Related News

Viking Q2 FY26 net income rises 33.8% to USD 587.7 million; revenue increases 16.5% to USD 2.19 billion

VIK•2026-08-19

Prime Medicine, Inc. <PRME.O>: BMO initiates coverage with outperform rating; price target $9

PRME•2026-08-19

LCNB names ex-Fifth Third chief legal officer Susan Zaunbrecher to board

LCNB•2026-08-19

Nebius Group plans unregistered sale of up to USD 4.5 billion convertible notes in private offering

NBIS•2026-08-19

Aurora Cannabis urges shareholders to take no action on Curaleaf’s US$4 per share hostile bid

ACB•2026-08-19

Amgen Inc <AMGN.O>: Argus Research Raises Target Price to $460 - AMGN News | Rallies